Vijaya Diagnostic Centre Ltd. · NSE:VIJAYA
Vijaya Diagnostic Centre — Merger or Acquisition (December 2023)
15 slides from Vijaya Diagnostic Centre's merger presentation, Dec 19, 2023
Slide 1: Investor Presentation – Acquisition (exchange filing letter)
December 19, 2023 To, To, Listing Department The Corporate Relations Department National Stock Exchange Of India Limited, BSE Limited, Exchange Plaza, Phiroz Jeejeebhoy Towers, Bandra Kurla Complex, 25th floor, Dalal Street, Bandra (East), Mumbai- 400 051 Mumbai - 400 001 NSE Symbol. VIJAYA BSE Scri
Slide 2: Announcement of Acquisition
Announcement of Acquisition
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Vijaya Diagnostic Centre Limited (the ‘Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for
Slide 4: About the company
About the company Disclaimer PH is Pune’s largest B2C focused Integrated Diagnostic Chain, with a remarkable 23 year legacy of Trust. PH was founded by Dr. Hemanth Dhoka in 2001, who is a Doctor by profession along with his family with a vision to deliver quality health care and convenience to the c
Slide 5: Management comments
Management comments Commenting on the acquisition, Ms. Suprita Reddy, MD & CEO at Vijaya Diagnostic Centre Ltd. said: “I am happy to announce the acquisition of P H Diagnostic, Pune’s largest B2C focused integrated diagnostic chain as part of our inorganic strategy. This acquisition will enable us t
Slide 6: Key Highlights
Key Highlights Type of Facility Services Available Count Hubs Sample collection, Ultrasound, X-Ray, 2D Echo, BMD, 3 MRI, CT etc., Spokes Sample collection, Ultrasound, X-Ray, 2D Echo etc., 3 Collection Centres (Company run) Sample collection only 12 Collection Centres (Franchisee) Sample collection
Slide 7: Business Proposition
Business Proposition Particulars VIJAYA PH Revenue Mix % - Radiology 36% ~ 43% - 47% - Pathology 64% ~ 53% - 57% Wellness Mix % 13% ~ 14% - 16% B2C Rev Mix % 95% ~ 85% - 90%
Slide 8: Transaction Value
Transaction Value Particulars Rs Mn Consideration for 100% Equity Shares (Secondary) 1,347 Payment towards Debt in the Target 128 Total Cost of acquisition of the Target 1,475 Mode of Payment Cash
Slide 9: Consultants appointed for the transaction
Consultants appointed for the transaction Consultant Engagement Deloitte Financial & Tax Diligence JSA Advocates & Solicitors Legal Diligence Price Waterhouse & Co. LLP Transaction Structuring RedSeer Market Study
Slide 10: High Quality Infrastructure
High Quality Infrastructure 9
Slide 11: Superior Facilities
ge. Superior Facilities VIJAYA ne; DIAGNOSTIC [WisavA] CENTRE The Pioneers in Diagnostic Medicare... 10
Slide 12: State-of-the-art Medical Equipment
State-of-the-art Medical Equipment 11
Slide 13: Customer Engagement
Customer Engagement Home Collection E Commerce Website Call Centre Whatsapp Chatbot Corporate Tie-ups 12
Slide 14: Investors Conference call
Investors Conference call Company will host a conference call shortly to discuss the acquisition of P H Diagnostic Centre Private Limited 13
Slide 15: Thank You
Thank You For further information please contact: Mr. Siva Rama Raju Head – Strategy & Investor Relations +91 99485 95555 sivaramaraju.v@vijayadiagnostic.in ir@vijayadiagnostic.in www.vijayadiagnostic.com Corporate Office : #6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad-500082,
Vijaya Diagnostic Centre — Merger or Acquisition (December 2023) on 6ix